The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 7, 1996, Pages 541-548

  Daling, Janet R ^a,b   Madeleine, Margaret M ^a,b   McKnight, Barbara ^a,b   Carter, Joseph J ^a   Wipf, Gregory C ^a   Ashley, Rhoda ^d   Schwartz, Stephen M ^a,b   Beckmann, Anna Marie ^a   Hagensce, Michael E ^a   Mandelson, Margaret T ^c   Galloway, Denise A ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX; VIRUS DETECTION; WART VIRUS;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONTRACEPTIVES, ORAL; DATA COLLECTION; FEMALE; HERPES GENITALIS; HUMANS; INCIDENCE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SMOKING; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 15844381340     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. zur Hauzen, H. Host cell regulation of HPV transforming gene expression. In: A. G. Knudson, Jr. et al. (eds.), Genetic Basis for Carcinogenesis: Tumor Suppressor Genes and Oncogenes, pp. 207-219. London: Taylor & Francis, Ltd., 1990.
2. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., and Shah, K. V. International Biological Study on Cervical Cancer (IBSCC) study group. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst., 87: 796-802, 1995.
3. McDougall, J. K. Cofactors in the progression of HPV-associated tumors. In: G. Giraldo, M. Salvatore, L. Chieco-Bianchi, and E. Beth-Giraldo (eds.), Advanced Technologies in Research, Diagnosis and Treatment of AIDS in Oncology, Vol. 46. pp. 150-164. Basel: Karger, 1994.
4. Hange, P., Brinton, L. A., Rosenthal, J. F., Cahill, J. I., Hoover, R. A., and Waksberg, J. Random digit dialing in selecting a population-based control group. Am. J. Epidemiol., 120: 825-833, 1984.
5. Carter, J. J., Wipf, G. C., and Hagensee, M. E. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J. Infect. Dis., 172: 11-18, 1995.
6. Ashley, R., and Militoni, J. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J. Virol. Methods, 18: 159-168, 1987.
7. Beckmann, A. M., Sherman, K. J., Myerson, D., Daling, J. R., McDougall, J. K., and Galloway, D. A. Comparative virologic studies of condylomata acuminata reveal a lack of dual infections with human papillomaviruses. J. Infect. Dis., 163: 393-396, 1991.
8. Gravitt, P. E., and Manos, M. M. Polymerase chain reaction based methods for the detection of human papillomavirus DNA. IARC Sci. Publ., 119: 121-133, 1992.
9. Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, U. A., and Araheim, N. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (Washington DC), 230: 1350-1354, 1985.
10. Rothman, K. J. Modern Epidemiology. Boston: Little Brown, 1986.
11. Nonnenmacher, B., Hubbert, N. L., Kimbauer, R., Shah, K. V., Munoz, N., Bosch, F. X., de San Jose, S., Viscidi, R., Lowy, D. R., and Schiller, J. T. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-posilive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J. Infect. Dis., 172: 19-24, 1995.
12. Wideroff, L., Schiffman, M. H., Nonnenmacher, B., Hubbert, N., Kirnbauer, R., Greer, C. E., Lowy, D., Lorinca, A. T., Manos, M. M., Glass, A. G., Scott, D. R., Sherman, M. E., Kurman, R. J., Buckland, J., Tarone, R. E., and Schiller, J. Evaluation of seropositivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J. Infect. Dis., 172: 1425-1430, 1995.
13. Daling, J. R., Sherman, K. J., Hislop, T. G., Maden, C., Mandelson, M. T., Beckmann, A. M., and Weiss, N. S. Cigarette smoking and the risk of anogenital cancer. Am. J. Epidemiol., 135: 180-189, 1992.
14. Slattery, M. L., Robison, L. M., Schuman, K. L., French, T. K., Stat, M., Abbott, T. M., Overall, J. C., and Gardner, J. W. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. J. Am. Med. Assoc., 261: 1593-1598, 1989.
15. Coker, A. L., Rosenberg, A. J., McCann, M. F., and Hulka, B. S. Active and passive cigarette smoke exposure to cervical intraepithelial neoplasia. Cancer EpidemioL, Biomarkers & Prev., 1: 349-356, 1992.
16. Brinton, L. A., Tashima, K. T., Lehman, H. F., Levine, R. S., Mallin, K., Savitz, D. A., Stolley, P. D., and Fraumcni, J. F. Epidemiology of cervical cancer by cell type. Cancer Res., 47: 1706-1711, 1987.
17. Munoz. N., Bosch, F. X., de Sanjose, S., and Shah, K. V. The role of HPV in the etiology of cervical cancer. Mutat. Res., 305: 293-301, 1994.
18. Herrero, R., Brinton, L. A., Reeves, W. C., Brenes, M. M., Tenorio, F., de Britton, R. C., Gaitan, E., Garcia, M., and Rawls, W. E. Invasive cervical cancer and smoking in Latin America. J. Natl. Cancer Inst., 81: 205-211, 1989.
19. Villa, L. L., Franco, E. L. F., and the Ludwig Institute for Cancer Research Human Papillomavirus Study Group. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J. Natl. Cancer Inst., 81: 332-340, 1989.
20. Garrett, L. R., Perez-Reyes, N., Smith, P. P., and McDougall, J. K. Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis (Lond.), 14: 329-332, 1993.
21. Holly, E. A., Petrakis, N. L., Friend, N. F., Sarles, D. L., Lee, R. E., and Flander, L. B. Mutagenic mucus in the cervix of smokers. J. Natl. Cancer Inst., 76: 983-986, 1986.
22. Jones, C. J., Schiffman, M. H., Kurman, R., Jacob, P., and Benowitz, N. L. Elevated nicotine levels in cervical lavages from passive smokers. Am. J. Public Health, 81: 378-379, 1991.
23. Wright, S. C., Zhong, J., Zheng, H., and Larrick, J. W. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J., 7: 1045-1051, 1993.
24. Simons, A. M., Phillips, D. H., and Coleman, D. V. Damage to DNA in cervical epithelium related to smoking tobacco. Br. Med. J., 306: 1444-1448, 1993.
25. Kjaer, S. K., Engholm, G., Dahl, C., Bock, J. E., Lynge, E., and Jensen, O. M. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use. Cancer Causes Control, 4: 513-519, 1993.
26. Brinton, L. A. Epidemiology of cervical cancer - overview. In: N. Munoz, F. X. Bosch, K. V. Shah, and A. Mehcus (eds.), The Epidemiology of Cervical Cancer and Human Papillomavirus, pp. 3-23. Lyon: IARC, 1992.
27. Brinton, L. A., Huggins, G. R., Lehman, H. F., Mallin, K., Savitz, D. A., Trapido, E., Rosenthal, J., and Hoover, R. Long-term use of oral contraceptives and risk of invasive cervical cancer. Int. J. Cancer, 38: 339-344, 1986.
28. Brinton, L. A., Reeves, W. C., Brenes, M. M., Herrero, R., de Britton, R. C., Gaitan, E., Tenorio, F., Garcia, M., and Rawls, W. E. Oral contraceptive use and risk of cervical cancer. Int. J. Epidemiol., 19: 4-10, 1990.
29. Louv, W. C., Austin, H., Perlman, H., and Alexander, W. J. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am. J. Obstet. Gynecol., 160: 396-402, 1989.
30. Harrison, H. R., Costin, M., Meder, J. B., Bownds, L. M., Sim, D. A., Lewis, M., and Alexander, E. R. Cervical Chamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis. Am. J. Obstet. Gynecol., 153: 244-251, 1985.
31. Gloss, B., Bernard, H. U., Seedorf, K., and Klock G. The upstream regulatory region of the human papillomavirus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J., 6: 3735-3743, 1987.
32. Chan, W., Chong, T., Bernard, H., and Klock, G. Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promoters throush APE binding sites. Nucleic Acids Res., 18: 763-769, 1990.
33. Mittal, R., Tsutsumi, K., Pater, A., and Pater, M. M. Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones. Obstet. Gynecol., 81: 5-12, 1993.
34. Mitrani-Rosenbaum, S., Tsvieli, R., and Tur-Kaspa, R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J. Gen. Virol., 70: 2227-2232, 1980.
35. Crook, T., Storey, A., Almond, N., Osborn, K., and Crawford, L. Human papillomavirus type 16 cooperates with activated ras and for oncogenes in the hormone-dependent transformation of primary mouse cells. Proc. Natl. Acad. Sci. USA, 85: 8820-8824, 1988.
36. Pater, A., Bayatpour, M., and Pater, M. M. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins form oral contraceptives. Am. J. Obstet. Gynecol., 162: 1099-1103, 1990.
37. Hildesheim, A., Mann, V., Brinton, L. A., Szklo, M., Reeves, W. C., and Rawls, W. E. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int. J. Cancer, 49: 1-6, 1991.
38. Munoz, N., Kato, I., Bosch, F. X., de Sanjose, S., Sundquist, V., Izarzugaza, I., Gonzalez, L. C., Tafur, L., Gili, M., Viladiu, P., Navarro, C., Moreo, P., Guerrero, E., Shah, K. V., and Wahren, B. Cervical cancer and herpes simplex virus type 2: case-control studies in Spain and Colombia, with special reference to immunoglobulin-G subclasses. Int. J. Cancer, 60: 438-442, 1995.
39. de Sanjose, S., Munoz, N., Bosch, F. X., Reimann, K., Pedersen, N. S., Orfila, J., Ascunce, N., Gonzalez, L. C., Tafur, L., Gili, M., Lette, I., Viladiu, P., Tormo, M. J., Moreo, P., Shah, K., and Wahren, B. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int. J. Cancer, 56: 358-363, 1994.